SCHEMBL5048904

SCHEMBL5048904

CC(C)(C)OC(=O)N[C@@H](Cc1ccc(-c2cnc3ccccc3c2)cc1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.58
NTSR1 P30989 1/20 0.56
ACE P12821 2/20 0.56
CTSS P25774 5/20 0.55
CTSK P43235 4/20 0.55
ITGA4 P13612 3/20 0.52
ITGB7 P26010 3/20 0.52
ITGB3 P05106 1/20 0.51
ITGA2B P08514 1/20 0.51
HDAC4 P56524 2/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC3 O15379 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1241026 0.91 CTSS (0.52) PTPN1NTSR1ACECTSSCTSK
SCHEMBL9743160 0.89 ACE (0.58) PTPN1ACECTSSCTSKITGB3
SCHEMBL7857022 0.89 ACE (0.58) PTPN1ACECTSSCTSKITGB3
SCHEMBL31407825 0.89 ACE (0.58) PTPN1ACECTSSCTSKITGB3
SCHEMBL23016701 0.85 CTSS (0.62) PTPN1ACECTSSCTSKITGA4
SCHEMBL17817170 0.85 CTSS (0.62) PTPN1ACECTSSCTSKITGA4
SCHEMBL1325181 0.85 CTSS (0.72) PTPN1ACECTSSCTSKITGA4
SCHEMBL1325182 0.85 CTSS (0.72) PTPN1ACECTSSCTSKITGA4
SCHEMBL1326276 0.85 CTSS (0.72) PTPN1ACECTSSCTSKITGA4
SCHEMBL8174447 0.84 ACE (0.57) PTPN1NTSR1ACECTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280909-A1 NEW PHENYLALANINE DERIVATIVES AJINOMOTO CO., INC. (JP) 2008-11-13 US disclosed
EP-1454898-A1 NOVEL PHENYLALANINE DERIVATIVE Ajinomoto Co., Inc. (JP) 2004-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280909-A1 NEW PHENYLALANINE DERIVATIVES ITGB4, VCAM1, ITGA4 PTPN1 1841/4885NTSR1 2689/4885ACE 3197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.